Evidence map›Paper›PMID 31100914›Full record

ArticleMolecules (Basel, Switzerland)2019

Antihypertensive Effects of Corn Silk Extract and Its Novel Bioactive Constituent in Spontaneously Hypertensive Rats: The Involvement of Angiotensin-Converting Enzyme Inhibition.

Chia-Cheng Li, Yu-Chen Lee, Hsin-Yi Lo, Yu-Wen Huang, Chien-Yun Hsiang, Tin-Yun Ho

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Extraction Optimization, Preliminary Identification, and Bioactivities in Corn Silk.Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chia-Cheng LiGraduate Institute of Chinese Medicine, China Medical University, Taichung 40402, Taiwan. u9551002@gmail.com.
Yu-Chen LeeGraduate Institute of Acupuncture Science, China Medical University, Taichung 40402, Taiwan. d5167@mail.cmuh.org.tw.ORCID 0000-0002-9510-3146
Hsin-Yi LoGraduate Institute of Chinese Medicine, China Medical University, Taichung 40402, Taiwan. hsinyilo0123@gmail.com.
Yu-Wen HuangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan. cute830811@yahoo.com.tw.
Chien-Yun HsiangDepartment of Microbiology and Immunology, China Medical University, Taichung 40402, Taiwan. cyhsiang@mail.cmu.edu.tw.ORCID 0000-0002-6507-8015
Tin-Yun HoGraduate Institute of Chinese Medicine, China Medical University, Taichung 40402, Taiwan. tyh@mail.cmu.edu.tw.ORCID 0000-0003-2390-1461
China Medical University · TWAsia University · TW

Funding

Ministry of Science and Technology MOST105-2320-B-039-017-MY3Ministry of Science and Technology MOST107-2320-B-039-029-MY3
6 · The paper itself

Abstract

Corn silk tea has been used in folk medicine for anti-hypertensive healthcare. Angiotensin-converting enzyme (ACE) plays a crucial role on the homeostasis of blood pressure. However, effects of corn silk tea on ACE activity and the presence of ACE inhibitory constituents in corn silk are still unknown. Here we applied proteomics and bioinformatics approaches to identify corn silk bioactive peptides (CSBps) that target ACE from the boiling water extract of corn silk (CSE). CSE significantly reduced systolic blood pressure (SBP) levels in spontaneously hypertensive rats and inhibited the ACE activity. By proteomics coupled with bioinformatics analyses, we identified a novel ACE inhibitory peptide CSBp5 in CSE. CSBp5 significantly inhibited the ACE activity and decreased SBP levels in a dose-dependent manner. Docking analysis showed that CSBp5 occupied the substrate-binding channel of ACE and interacted with ACE via hydrogen bonds. In conclusion, we identified that CSE exhibited anti-hypertensive effects in SHRs via the inhibition of ACE, the target of most anti-hypertensive drugs. In addition, an ACE inhibitory phytopeptide CSBp5 that decreased SBP levels in rats was newly identified. Our findings supported the ethnomedical use of corn silk tea on hypertension. Moreover, the identification of ACE inhibitory phytopeptide in corn silk further strengthened our findings.

Indexed as

Amino Acid SequenceAngiotensin-Converting Enzyme InhibitorsAnimalsAntihypertensive AgentsBlood PressureChromatography, LiquidDisease Models, AnimalDose-Response Relationship, DrugHydrogen BondingHypertensionMaleModels, MolecularPeptidesPlant ExtractsProtein ConformationRatsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsPeptidesPlant Extractsangiotensin-converting enzymebioactive phytopeptidecorn silkhypertension

Identifiers

PMID31100914
PMCPMC6572293
OpenAlexW2946117356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.